Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Catriona Jamieson is Chief of the Division of Regenerative Medicine at UC San Diego Health Moores Cancer Center as well as Associate Professor of Medicine and Hematology Team Leader for the Division of Hematology/Oncology. Dr. Jamieson is a board-certified hematologist with broad clinical expertise in caring for patients with hematologic malignancies. Her clinical interests include the treatment of myeloproliferative neoplasms (MPNs) including chronic myeloid leukemia (CML), polycythemia vera (PV), myelofibrosis (MF) and essential thrombocythemia (ET). Dr. Jamieson serves as the principal investigator on several clinical trials for the treatment of these and related bone marrow disorders.
Dr. Jamieson is a leading physician-scientist who discovered missplicing, RNA hyper-editing and splice isoform switching as mechanisms governing human cancer stem cell maintenance in selective niches. This pioneering cancer stem cell research has transformed therapies, including JAK2 and sonic hedgehog-inhibitor trials for myeloproliferative neoplasm and leukemia stem cell targeting.